PB2471: EFFECT OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION WITH MODIFIED FC PRETREATMENT REGIMEN ON SEX HORMONE LEVELS IN CHILDREN WITH SEVERE APLASTIC ANEMIA

por MA, Liangming, Shi, Keru, Wang, Dan
Publicado 2023

PB2468: A RETROSPECTIVE STUDY OF ELTROMBOPAG IN PATIENTS WITH THROMBOCYTOPENIA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION

por MA, Liangming, Wang, Dan, Shi, Keru
Publicado 2023

Therapeutic efficacy and infectious complications of CD19-targeted chimeric antigen receptor-modified T cell immunotherapy

por Gao, Zhilin, Lian, Yu, Ti, Juanjuan, Ren, Ruirui, Ma, Liangming
Publicado 2023

Acute intestinal GVHD following donor-derived CD7-CAR-T-cell infusion in a child with Omicron COVID-19

por Lian, Yu, Gao, Zhilin, Ti, Juanjuan, Yu, Zhuanzhuan, Ma, Liangming, Wei, Jia
Publicado 2023

Carfilzomib inhibits the proliferation and apoptosis of multiple myeloma cells by inhibiting STAT1/COX-2/iNOS signaling pathway

por He, Shaolong, Tian, Weiwei, Zhao, Jie, Gong, Rong, Wang, Tao, Ma, Liangming
Publicado 2022

P1033: JAKTINIB IN PATIENTS WITH MYELOFIBROSIS WHO WERE REFRACTORY OR RELAPSED TO RUXOLITINIB: A SINGLE-ARM, OPEN-LABEL, MULTICENTER, PHASE 2 STUDY

por Zhang, Yi, Zhang, Qike, Liu, Qingchi, Dang, Huibing, Gao, Sujun, Wang, Wei, Zhou, Hu, Chen, Yuqing, MA, Liangming, Wang, Jishi, Zhao, Peng, Yang, Haiping, Zhao, Qingwei, Suo, Shanshan, Jin, Jie
Publicado 2023

P959: MAINTENANCE THERAPY FOLLOWED AUTOLOGOUS STEM CELL TRANSPLANTATION BY IXAZOMIB AND/OR LENALIDOMIDE IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A MULTICENTERED REAL WORL...

por Lu, Minqiu, Liu, Ai-Jun, Chen, Wen-Ming, Wu, Yin, Fu, Rong, Jing, Hongmei, Dong, Fei, MA, Liangming, Tian, Weiwei, MA, Yanping, Chu, Bin, Wang, Yutong, Kai, Sun, Zhuang, Junling, Bao, LI
Publicado 2023

P873: IXAZOMIB VERSUS LENALIDOMIDE OR IXAZOMIB AND LENALIDOMIDE COMBINATION AS MAINTENANCE REGIMEN FOR TRANSPLANT-INELIGIBLE MULTIPLE MYELOMA: UPDATE OF A MULTI-CENTER PROSPECTIVE...

por Zhuang, Zhe, Tian, Ying, Shi, Lei, Yu, Hong, Liu, Qinhua, Zou, Dongmei, Tian, Weiwei, Feng, Ru, Dong, Fei, MA, Yanping, Liu, Shuangjiao, Jing, Hongmei, Liu, Hui, MA, Liangming, Sun, Wanling, Fu, Rong, Bao, LI, Wu, Yin, Chen, Wenming, Zhuang, Junling
Publicado 2023

P1021: JAKTINIB IN PATIENTS WITH MYELOFIBROSIS WHO WERE INTOLERANT TO RUXOLITINIB: AN OPEN-LABEL, SINGLE-ARM PHASE 2B STUDY

por Zhang, Yi, Zhou, Hu, Xiao, Zhijian, Duan, Minghui, Gao, Sujun, He, Guangsheng, Jing, Hongmei, LI, Junmin, MA, Liangming, Zhu, Huanling, Chang, Chunkang, Du, Xin, Hong, Mei, LI, Xin, Liu, Qingchi, Wang, Wei, Na, Xu, Yang, Haiping, Zhao, Qingwei, Jin, Jie
Publicado 2023

2021 Chinese consensus on the diagnosis and management of primary immune thrombocytopenia in pregnancy

por Zhang, Xiaohui, Chen, Fangping, Chen, Xiequn, Cheng, Yunfeng, Fang, Meiyun, Feng, Jianming, Fu, Haixia, Gao, Hong, Han, Yue, He, Aili, Hou, Ming, Hu, Yu, Huang, Ruibin, Huang, Wenrong, Jing, Zhicheng, Kong, Peiyan, Liang, Aibin, Liang, Meiying, Liu, Daihong, Liu, Junling, Liu, Lin, Liu, Xiaowei, Ma, Liangming, Mei, Heng, Ni, Heyu, Niu, Ting, Peng, Jun, Qiao, Jianlin, Ren, Jinhai, Song, Yongping, Tang, Liang V., Tong, Tong, Wang, Shaoyuan, Wang, Xin, Wang, Zhao, Wei, Hui, Wu, Depei, Wu, Guangsheng, Xu, Caigang, Xu, Xue, Xu, Yajing, Yang, Linhua, Yang, Renchi, Yang, Tonghua, Yin, Chenghong, Yu, Li, Zhang, Guangsen, Zhang, Lei, Zhang, Liansheng, Zhang, Xi, Zhao, Weili, Zhao, Yongqiang, Zhou, Daobin, Zhou, Hu, Zhou, Zeping, Zhu, Tienan, Wang, Jianliu, Huang, Xiaojun
Publicado 2022